Key Market Indicators
Sales of digestive system disorder medicines in Austria are expected to reach $392 million by 2026. In 2021, the figure was $382 million, representing year-on-year growth of 0.4%. Since 2015, the Austrian market has been growing at an average rate of 3.1% per year. In 2021, Austria ranked 17th in the world in terms of digestive system disorder medicine sales, with Denmark coming in ahead at $382 million. Japan, South Korea and Canada followed as the second, third and fourth-largest markets respectively.
